Process Development and Scale-Up of a Novel Atypical DAT Inhibitor (
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
19 Mar 2024
19 Mar 2024
Historique:
received:
23
11
2023
revised:
08
02
2024
accepted:
14
02
2024
medline:
25
3
2024
pubmed:
25
3
2024
entrez:
25
3
2024
Statut:
epublish
Résumé
Large-scale syntheses of small molecules and kilo laboratories are crucial steps in drug development, especially in advanced stages. (
Identifiants
pubmed: 38524446
doi: 10.1021/acsomega.3c09348
pmc: PMC10956084
doi:
Types de publication
Journal Article
Langues
eng
Pagination
12976-12983Informations de copyright
© 2024 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.